article thumbnail

PhRMA lies to protect pharma profits

World of DTC Marketing

Such warnings “constitute the pharma response in literally every instance since 1906,” the first drug regulation agency was created, said Dr. Aaron Kesselheim. The post PhRMA lies to protect pharma profits appeared first on World of DTC Marketing.com. Amazon’s operating margin is under 5 percent.

Pharma 255
article thumbnail

Pharma Horizons: Sustainability

European Pharmaceutical Review

Register your details now to download >>> This Pharma Horizons report is brought to you in association with: The post Pharma Horizons: Sustainability appeared first on European Pharmaceutical Review. How the industry can benefit from designing chemistry processes with a sustainable approach from the outset.

Pharma 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharma Horizons: Artificial Intelligence

European Pharmaceutical Review

The first in our inaugural Pharma Horizons report series is dedicated to exploring the latest advances in artificial intelligence (AI) and machine learning (ML) for drug development, pharmaceutical manufacturing and quality control. Additionally the pharmaceutical AI market is projected to reach $11.8

Pharma 130
article thumbnail

Why today’s leading pharma manufacturers are adopting proactive asset management strategies

PharmaVoice

In recent months, high-profile drug shortages have brought pharmaceutical manufacturing operations into the spotlight.

article thumbnail

Pharma unite to secure renewable energy in key manufacturing markets

European Pharmaceutical Review

This step is important as these countries are key markets for pharmaceuticals manufacturing. GSK propels its progress to Net Zero Renewable energy in the pharma supply chain The SMI Health Systems Task Force is a public-private partnership launched at COP26.

article thumbnail

Common pharma compliance concerns cited by FDA warning letters

European Pharmaceutical Review

Warning letters issued by FDA can be an important source of data to study and analyse violations that occur in pharmaceutical manufacturing. The post Common pharma compliance concerns cited by FDA warning letters appeared first on European Pharmaceutical Review. What can we learn from contamination control failures?

FDA 105
article thumbnail

Innovating pharma at the edge

European Pharmaceutical Review

A recent report from the International Data Corporation (IDC), based on extensive research in pharma and life sciences, highlights the requirement for increased operational efficiency and explores the key drivers that are encouraging innovation for pharma companies, now and into the future.

Pharma 98